- Home
- BWAY vs VOR Comparison
BWAY vs VOR Comparison
Compare BWAY & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- VOR
- Stock Information
- Founded
- BWAY 2003
- VOR 2015
- Country
- BWAY Israel
- VOR United States
- Employees
- BWAY N/A
- VOR N/A
- Industry
- BWAY Medical/Dental Instruments
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- BWAY Health Care
- VOR Health Care
- Exchange
- BWAY Nasdaq
- VOR Nasdaq
- Market Cap
- BWAY 216.8M
- VOR 202.4M
- IPO Year
- BWAY 2019
- VOR 2021
- Fundamental
- Price
- BWAY $11.47
- VOR $2.10
- Analyst Decision
- BWAY Strong Buy
- VOR Buy
- Analyst Count
- BWAY 2
- VOR 7
- Target Price
- BWAY $14.25
- VOR $3.77
- AVG Volume (30 Days)
- BWAY 47.5K
- VOR 11.3M
- Earning Date
- BWAY 08-13-2025
- VOR 08-11-2025
- Dividend Yield
- BWAY N/A
- VOR N/A
- EPS Growth
- BWAY N/A
- VOR N/A
- EPS
- BWAY 0.08
- VOR N/A
- Revenue
- BWAY $43,457,000.00
- VOR N/A
- Revenue This Year
- BWAY $341.83
- VOR N/A
- Revenue Next Year
- BWAY $23.42
- VOR N/A
- P/E Ratio
- BWAY $56.90
- VOR N/A
- Revenue Growth
- BWAY 26.86
- VOR N/A
- 52 Week Low
- BWAY $5.98
- VOR $0.13
- 52 Week High
- BWAY $13.66
- VOR $3.29
- Technical
- Relative Strength Index (RSI)
- BWAY 41.46
- VOR 56.27
- Support Level
- BWAY $11.54
- VOR $2.03
- Resistance Level
- BWAY $12.08
- VOR $2.38
- Average True Range (ATR)
- BWAY 0.50
- VOR 0.27
- MACD
- BWAY -0.12
- VOR -0.08
- Stochastic Oscillator
- BWAY 7.20
- VOR 24.66
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.